TJP1 and breast cancer: The Cui et al. study previously reported that silencing ROR1 reversed the EMT procedure in breast cancer, as indicated by reduced SNAIL-1/2, ZEB1 and vimentin, and increased ZO-1 and E-cadherin [20].